| Dabigatran etexilate |
达比加群酯 |
211915-06-9 |
| LY411575 |
(AS)-N-[(1S)-2-[[(7S)-6,7-二氢-5-甲基-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟-ALPHA-羟基苯乙酰胺 |
209984-57-6 |
| DIBENZAZEPINE |
二苯并氮卓 |
209984-56-5 |
| Z-DEVD-FMK |
CASPASE-3抑制剂 |
210344-95-9 |
| ML-323 |
ML323 |
1572414-83-5 |
| CB-839 |
CB-839 |
1439399-58-2 |
| OTSSP 167 hydrochloride |
1-[6-(3,5-二氯-4-羟基苯基)-4-[[反式-4-[(二甲基氨基)甲基]环己基]氨基]-1,5-萘啶-3-基]-乙酮 |
1431697-89-0 |
| 2,4-PyriMidinediaMine with linker |
N2-[4-[(3-氨基丙基)氨基]苯基]-N4-(5-环丙基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
1430089-64-7 |
| (Z)-3-(3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3- |
KPT-276 |
1421919-75-6 |
| KPT-330 |
塞利尼索 |
1393477-72-9 |
| GNE-0877 |
GNE-0877 |
1374828-69-9 |
| SSE15206 |
1370046-40-4 |
1370046-40-4 |
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyraMide |
BMS-5 |
1338247-35-0 |
| ASP-2215 |
吉列替尼 |
1254053-43-4 |
| RQ-00203078 |
4-(N-(3-氯-5-(三氟甲基)吡啶-2-基)-N-(4-(三氟甲氧基)苄基)氨基磺酰基)苯甲酸 |
1254205-52-1 |
| A-485 |
1889279-16-6 |
1889279-16-6 |
| EFT-508 |
6'-[(6-氨基-4-嘧啶基)氨基]-8'-甲基螺[环己烷-1,3'(2'H)-咪唑并[1,5-A]吡啶]-1',5'-二酮 |
1849590-01-7 |
| BLU-285 |
阿伐普替尼 |
1703793-34-3 |
| AZD 3759 |
AZD3759 |
1626387-80-1 |
| AZD3264 |
AZD3264 |
1609281-86-8 |
